Market Overview:
The global platelet rich plasma market size is expected to reach USD 2,783.89 million by 2032, exhibiting a CAGR of 14.5% during the forecast period.
The need for platelet rich plasma has grown as a result of its approval in the arena of cosmetic surgery and dermatology for its possibility to improve skin revival and accelerate the mending procedure. It is dispensed either nominally or through injections into the skin, with the objective of restoring collagen manufacturing, clarifying skin appearance, decreasing lines and wrinkles, and realizing a holistic reinvigorated facial advent.
Platelet rich plasma depends on platelets to enhance tissue concern. Varied types of PRP commodities are normally administered as injections to mend and restore wounds. The task of the platelets in the body is to assist blood clots when there is a wound. The cytokines and developmental factors that are present in the platelets can assist in restoring wounds and motivate healing. It can be useful in curing tennis elbow, knee osteoarthritis, sports wounds such as dragged muscles, joint sprains, and ligament tears. It also treats wounds or hair loss.
Competition Categorization
Making locally to decrease functional prices is one of the critical business schemes utilized by makers in the market to profit clients and surge their market sector. Key companies in the platelet rich plasma (PRP) market are mentioned below:
- Apex Biologix
- Arthrex Inc.
- Dr. PRP USA LLC
- Isto Biologics
- Juventix Regenerative Medical, LLC
- Regen Lab SA
- RegenOrthoSport
- Terumo Cardiovascular Systems Corporation
- Vivostat
- Zimmer Biomet
Key Takeaways from the Report
- The primary factors propelling the market growth of platelet rich plasma are the growing usage of PRP for mending detrimental illnesses such as orthopaedic, cardiovascular or neurovascular illnesses as well as implementation in common surgery and wound handling.
- The platelet rich plasma (PRP) market analysis is mainly based on type, application, end use, and region.
- North America dominated the market.
- The market in Europe will increase as a result of factors like the extensive acquisition of PRP therapy for curing musculoskeletal wounds.
Segmental Overview:
Platelet Rich Plasma (PRP) Market, Type Outlook (Revenue – USD Million, 2019-2032)
- Pure Platelet-Rich Plasma (P-PRP)
- Leukocyte-and Platelet-Rich Plasma (L-PRP)
- Pure Platelet-Rich Fibrin (P-PRF) – or Leukocyte-Poor Platelet-Rich Fibrin
- Leukocyte- and Platelet-Rich Fibrin (L-PRF)
Platelet Rich Plasma (PRP) Market, Application Outlook (Revenue – USD Million, 2019-2032)
- Orthopedics
- Sports Medicine
- General Surgery
- Dermatology
- Ophthalmology
- Neurology
- Cardiology
- Others
Platelet Rich Plasma (PRP) Market, End-Use Outlook (Revenue – USD Million, 2019-2032)
- Hospitals
- Clinics
- Others
Recent Developments in the Platelet Rich Plasma (PRP) Industry:
- Crown Aesthetics Rebrand (November 2022)
Crown Aesthetics rebranded its ProGen PRP Advantage system to ProGen PRP Eclipse, introducing an advanced and user-friendly platelet-rich plasma system designed to provide consistent results. This rebranding emphasizes the company’s commitment to offering cutting-edge solutions for PRP therapy, with enhanced ease of use for healthcare professionals. - Isto Biologics Acquisition (April 2022)
Isto Biologics acquired TheraCell Inc., a strategic move to strengthen its position in orthobiologic regeneration technologies and cell-based therapies, particularly for spine and orthopedic care. This acquisition expands Isto’s portfolio, enabling more innovative treatments in regenerative medicine. - APEX Biologix Launch (April 2019)
APEX Biologix launched its new and improved PRP system, registered under 510 K number BK180252, after refining the design based on feedback from physicians. The system was developed to be both accessible and cost-effective, while still providing high-quality results for platelet-rich plasma therapy, catering to the growing demand in aesthetic and therapeutic treatments.
The demand for platelet-rich plasma is experiencing robust growth across various medical and aesthetic fields globally. PRP’s versatility in treating a wide range of conditions, including musculoskeletal injuries like tendonitis, arthritis, and sports-related injuries, has significantly contributed to its popularity. In orthopedics, PRP is increasingly used to expedite healing and reduce recovery times post-surgery, appealing to both athletes and aging populations alike seeking non-invasive treatment options.